Filing Flows › AstraZeneca (AZN) › Q2 2026 › vs Q2 2025
AstraZeneca (AZN) Q2 2026 vs Q2 2025 (year over year)
AstraZeneca's revenue rose $2.6B (+9%) from $28.0B in Q2 2025 to $30.7B in Q2 2026. Gross margin 83.0% against 83.2% (-0.1 pts).
AstraZeneca, Q2 2026: revenue $30.7B (+9% year over year), operating margin 24.2%, net earnings $5.6B. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 83.0% | 83.2% | -0.1 pts |
| Operating margin | 24.2% | 25.6% | -1.5 pts |
| Net margin | 18.2% | 19.1% | -0.9 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $30.7B | $28.0B | $2.6B | +9% |
| Gross profit | $25.5B | $23.3B | $2.1B | +9% |
| Cost of revenue | $5.2B | $4.7B | $487M | +10% |
| Operating profit | $7.4B | $7.2B | $228M | +3% |
| Operating expenses | $18.1B | $16.1B | $1.9B | +12% |
| Pre-tax earnings | $6.7B | $6.5B | $184M | +3% |
| Other expense, net | $697M | $653M | $44.0M | +7% |
| Net earnings | $5.6B | $5.4B | $220M | +4% |
| Income tax | $1.1B | $1.2B | −$36.0M | -3% |
Questions
How much did AstraZeneca's revenue grow year over year in Q2 2026?
AstraZeneca's revenue rose $2.6B (+9%) from $28.0B in Q2 2025 to $30.7B in Q2 2026. Gross margin 83.0% against 83.2% (-0.1 pts).